Story thread · 6 reports / 6 sources
STAT+: China tightens the reins on clinical trials, even as the U.S. looks for ways to replicate its rival’s speed
statnews.com · 1d
How the coverage leans
Across 6 sources · syndicated copies counted once
China has tightened regulations on investigator-initiated trials, with consequences not just for Chinese researchers but some Americans, too.
First report: Kalshi and Polymarket bets on clinical trials criticized as 'ghastly' — npr.org, 4d
The coverage
The conversation · 0
Sign in to join the conversation.
No comments yet — start the thread.